Expo Hub
Molecular imaging in lung cancer
About this session
Examining the role of molecular imaging in lung cancer from initial diagnosis through post-therapy follow-up with Dr. Ryan Avery, Associate Professor of Cardiovascular Imaging & Nuclear Medicine, Director of Nuclear Medicine, and Director of Advanced Imaging & Analytics Laboratory in the Department of Radiology at Northwestern Medicine.
1 / 0
Ryan Avery
Director of Advanced Imaging & Analytics Laboratory in the Department of Radiology at Northwestern Medicine, Chicago, Illinois, USA
Related sessions
1 / 0
A practical approach to Liver Magnetic Resonance Imaging (MRI) interpretation: an interactive session
Case discussion with Prof. Dr. Kartik Jhaveri from University of Toronto
Initial Test for HCC Surveillance - MRI or CEUS? | The DAX Probe - A CEUS Game Changer
Learn key findings on nodules identified on surveillance US for HCC: CEUS or MRI as the initial test, and quality improvements in contrast enhanced ultrasound (CEUS) for patients with High BMI and gross fatty liver.
Role of Artificial Intelligence (AI) in Lung Cancer Screening Program
Identifying smoking-related disease on LCS CT scans and the role of AI in LCS
Quantitative ultrasound in patients with liver steatosis and non-alcoholic steatohepatitis
Join our live Ultrasound demonstration to see the advantages in patient assessments of liver steatosis and non-alcoholic steatohepatitis for liver stiffness and fatty infiltration.